🟢 Senti Biosciences is trading 9.47% up in after-hours trading amid biotech-sector optimism around AI-enabled drug discovery

Senti Biosciences is trading up 9.47% at $0.37 in after-hours trading amid sector-driven biotech optimism surrounding AI-enabled drug discovery.

• Shares closed at $0.34 on September 23, 2026.
• No new company-specific announcement or late-breaking catalyst was identified.
• Recent filing coverage involved an S-3/A amendment updating auditor consent. The strategic SENTI-202 transaction was announced previously, not on September 23, 2026.